Redesigning Life’s Blueprint

GERONYX (জেরোনিক্স) is a biotech company pioneering science‑backed therapies to extend healthy lifespan. Our debut product, OcuveraX, delivers next‑generation true vision — a breakthrough in amblyopia therapy available and affordable in Bangladesh.

OcuveraX logo

Mission & Vision

Mission

Extend Human Healthspan

We are committed to translating frontier science into real therapies that expand human life. Starting with vision and neural health in Bangladesh, we’ll build towards longevity and life extension platforms for the globe.

Vision

South Asia’s Life‑Extension Flagship

To become South Asia’s trusted leader in life‑extension biotech, building devices, software and therapies that deliver measurable improvements in quality of life and longevity.

Introducing OcuveraX

What

Innovative Therapy

An accessible amblyopia solution combining a home therapy kit with a gamified mobile app and clinician dashboard, enabling patients to improve lazy eye effectively.

Why

True Vision for All

Millions suffer from amblyopia without affordable treatment. OcuveraX addresses this gap by offering science‑backed therapy localized for Bangla speakers and priced for accessibility.

How

Data & Outcomes

Combines dichoptic training, personalized exercises, and adherence tracking. Planned clinical validation with ophthalmology partners aims for measurable acuity improvements within 12 weeks.

Why Invest in GERONYX

Market

Underserved Need

The South Asian amblyopia market lacks localized, evidence‑based therapy options, offering a clear entry point to capture value and build brand trust.

Model

Product & Subscription

Revenue is driven by kit sales, app subscriptions and B2B partnerships with clinics and insurers, yielding strong margins and predictable recurring revenue.

Future

Longevity Roadmap

After establishing dominance in vision therapy, our R&D pipeline moves into neuro‑vision health and longevity biotech, creating long‑term growth opportunities.

Get in Touch

Schedule a meeting

Interested in pilots, partnerships or investment? We would love to chat.

Schedule

General inquiries

Have questions or feedback? Send us a message and we’ll respond promptly.

Send Message